Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to Board of Directors
June 29, 2018 09:15 ET
|
Marina Biotech, Inc.
City of Industry, CA, June 29, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative...
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
June 20, 2018 11:30 ET
|
Marina Biotech, Inc.
City of Industry, CA, June 20, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative...
Marina Biotech Announces a New Publication on Prestalia®
February 27, 2018 10:15 ET
|
Marina Biotech, Inc.
City of Industry, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Ligandal CEO Unveils Nanotech Delivery for Genetic Therapies: “What Good Would Amazon Be Without the Shipping?”
February 07, 2018 20:08 ET
|
Ligandal Inc
SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cures for sickle cell, hemophilia and a host of other genetic-based diseases are on the horizon because of nanotechnology that can now deliver CRISPR,...
Marina Biotech Announces Agreement for Drug Development and Licensing with Autotelic Bio
January 16, 2018 08:40 ET
|
Marina Biotech, Inc.
City of Industry, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...